Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0000899243-22-018605 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-18 | 2022-05-16 | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $252.83 | -45 | 41.7K | -0.1% | -$11.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | S | D | 7 | $250.56 | 41,787 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87). |
| 2 | Common | Common Stock | 2022-05-16 | S | D | 8 | $251.37 | 41,779 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88). (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-05-16 | S | D | 7 | $252.43 | 41,772 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07). (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-05-16 | S | D | 15 | $253.99 | 41,757 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32). (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2022-05-16 | S | D | 8 | $254.44 | 41,749 | D | — | — | (F2) Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57). |